Sanity Group
Unlocking the potential of cannabinoids to develop innovative pharmaceuticals and well-being products.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD205—308m (Dealroom.co estimates Sep 2022.)
Company register number HRB 206368 B (Charlottenburg (Berlin))
Berlin Germany (HQ)
Financials
Estimates*
| EUR | 2019 |
|---|---|
| Profit | (1.2m) |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
€10.0m | Seed | ||
$22.0m | Seed | ||
N/A | Seed | ||
€4.0m Valuation: €110m | Angel | ||
* | N/A | Media For Equity | |
$44.2m | Series A | ||
$3.5m Valuation: $221m | Series A | ||
* | $37.6m | Series B | |
* | $2.7m | Secondary | |
* | $12.3m | Convertible | |
| Total Funding | CAD184m | ||
Related Content
Recent News about Sanity Group
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.